Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Transfusion-transmitted infections.

Florian Bihl1, Damiano Castelli, Francesco Marincola

  • 1Partners AIDS Research Center, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA. f.bihl@mac.com

Journal of Translational Medicine
|June 8, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

First-time blood donor demographics and characteristics during the individual donor assessment versus 3-month deferral policies for high-risk behaviors.

Transfusion·2026
Same author

Antiretroviral therapy blocks natural selection on protective and disease-susceptible HLA-B alleles in HIV-1 infection.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same author

PD-1 blockade enhances functional vaccine-induced HIV-1 CD8<sup>+</sup> T-cell responses in PWH receiving early ART.

EBioMedicine·2025
Same author

Predictors of virological outcomes after analytical interruption of antiretroviral therapy and HTI vaccination in early treated people with HIV-1._.

Communications medicine·2025
Same author

Prevalence of HIV, HBV, and HCV in United States blood donations, 2015-2023: The transfusion-transmissible infections monitoring system (TTIMS).

Transfusion·2025
Same author

Strategies to Minimize Time From HIV Acquisition to ART Initiation: The Barcelona Early-cART Program.

Open forum infectious diseases·2025
Same journal

The lncRNA-m6A axis in cancer: a bidirectional regulatory network in tumor progression and therapeutic resistance.

Journal of translational medicine·2026
Same journal

Repurposing cepharanthine as a radiosensitizer in esophageal squamous cell carcinoma through dual metabolic intervention and direct targeting of p70s6K.

Journal of translational medicine·2026
Same journal

Cellular crosstalk and signaling networks in the rheumatoid arthritis synovial microenvironment.

Journal of translational medicine·2026
Same journal

Pilot spatial transcriptomics of dental pulpitis suggests immune-fibroblast profiling linked to reversibility.

Journal of translational medicine·2026
Same journal

Beyond semen analysis: in men with normal semen parameters telomere attrition and oxidative imbalance distinguish those fertile from those with infertility.

Journal of translational medicine·2026
Same journal

Dual-block HER2 assessment reveals clinically relevant intratumoral heterogeneity in gynecologic cancers: a single-center landscape analysis.

Journal of translational medicine·2026
See all related articles

Ensuring a safe blood supply requires continuous improvement in donor selection, screening, and pathogen inactivation methods to prevent transfusion-transmitted infections. Collaboration among transfusion medicine stakeholders and robust surveillance are vital for mitigating risks from known and emerging blood-borne pathogens.

Area of Science:

  • Transfusion Medicine
  • Infectious Disease Control
  • Public Health

Background:

  • The risk of transfusion-transmitted infections (TTIs) is reduced but not eliminated.
  • Blood products can be contaminated with known and unknown human pathogens.
  • Maintaining a safe blood supply is an ongoing challenge.

Purpose of the Study:

  • To highlight the importance of continuous improvement in blood safety measures.
  • To emphasize the need for comprehensive strategies against transfusion-transmitted infections.
  • To underscore the role of surveillance and collaboration in blood product security.

Main Methods:

  • Review of current practices in donor selection and screening.
  • Evaluation of pathogen inactivation technologies.

Related Experiment Videos

  • Discussion of the role of haemovigilance and education.

    • Main Results:

    • Stringent donor selection, sensitive screening, and effective inactivation are key to reducing TTI risks.
    • Ongoing education and reporting of adverse events are crucial for surveillance.
    • Collaboration is essential for addressing both known and emerging blood-borne pathogens.

    Conclusions:

    • A multi-faceted approach combining improved donor screening, inactivation, and surveillance is necessary for blood safety.
    • Proactive measures and stakeholder collaboration are vital to protect against transfusion-transmitted infections.
    • Continuous vigilance is required to safeguard the blood supply from evolving infectious threats.